Cardionomix
Tracked across 1 events · 6 articles · First seen Jul 06, 2026 · Last active Jul 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Cardionomix, a medical device company owned by Catheter Precision, received a patent for systems and methods for denoising physiological signals during electrical neuromodulation, enhancing its technology for treating acute decompensated heart failure.
Jul 06, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Cardionomix live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard